Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

New biopharma start-up at Lille's Institut Pasteur

10 Aug 2016 | Health Nutrition, A region on the move

A revolutionary start-up has just seen the light of day at the Institut Pasteur campus in Lille. Immune InsighT is a biotech business specialized in analyses to confirm new drug candidates are safe. The company harnesses rare expertise to offer a unique services to clients around the world.

Lille's Institut Pasteur is an international pace-setter and a key player in medical research. Over the past fifteen years, a dozen start-ups have been set up on its campus or through its research teams—including Immune InsighT in 2016.

Immune InsighT offers an all-new, high-end method for confirming the safety of new drug candidates designed to treat cancer, transplants, auto-immune system and inflammatory illnesses, and applications in agrifood and the cosmetic industry prior to the launch of clinical tests. This fast-moving young company offers unique services worldwide.

Completing the full range of tests offered by Immune InsighT early on enables client companies to identify the undesirable effects of drug candidates or other molecules on the immune system both reliably and quickly—and to anticipate the potential failure of a long and costly clinical trial well in advance. 

 

Source: Lille's Institut Pasteur

Back to news

News

Inovet invests €26M in Hauts-de-France

Thanks to this investment, veterinary pharmaceutical products specialist Biové (Inovet Group) aims to triple production capacity within five years.

Daily maritime link between Calais and Tilbury

The maritime route between the Hauts-de-France and the United Kingdom has been further strengthened with P&O Ferries’ launch of a daily freight service between Calais and Tilbury, a port situated at the...

All news